Associate Clinical Professor of Medicine, Joslin Diabetes Center
Endocrinology
Dr. Om P. Ganda, MD
|
|
Give Review
Ganda is an expert in the field of Endocrinology. He graduated from Sawai Man Singh Medical College. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Diabetes Recognition Program". Ganda is a published doctor. He published 75 publications, including: 'A comparison of thyroxine and desicatted thyroid in patients with primary hypothyroidism.' He accepts all Medicare patients.
Publications
- Impact of Reinforcement of Diabetes Self-Care on Poorly Controlled Diabetes: A Randomized Controlled Trial.
- Do Older Adults Aged 60 to 75 Years Benefit From Diabetes Behavioral Interventions?
- Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in pa...
- Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.
- The Effect of a Structured Behavioral Intervention on Poorly Controlled Diabetes: A Randomized Controlled Trial.
- The role of bile acid sequestrants in the management of type 2 Diabetes mellitus.
- Salt sensitivity, insulin resistance, and public health in India.
- Refining lipoprotein assessment in Diabetes: apolipoprotein B makes sense.
- A targeted, multifactorial intervention reduced mortality in patients with type 2 Diabetes and microalbuminuria.
- Review: meglitinide analogues reduce glucose levels in type 2 Diabetes, but morbidity and mortality effects are unknown.
- Migration and its impact on adiposity and type 2 Diabetes.
- Ask the doctor. I have been taking niacin for several years, and it has helped keep my good and bad cholesterol in their healthy ranges. Now I have been diagnosed With...
- Should group education classes be separated by type of Diabetes?
- The role of lipid management in Diabetes.
- American College of Endocrinology position statement on the insulin resistance Syndrome.
- Review: interventions that lower cholesterol levels or blood pressure in Diabetic patients prevent cardiovascular disease.
- Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 Diabetes: results of the assessment of Diabetes contro...
- Insulin resistance Syndrome: implications for the Asian American population.
- Prevalence of diabetes, metabolic Syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study.
- American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a Diabetes mellitus comprehensive care plan: executive summary.
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a Diabetes mellitus comprehensive care plan.
- Valsartan improves resting skin blood flow in Type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation.
- AACE medical guidelines for clinical practice for the diagnosis and treatment of dysLipidemia and prevention of atherogenesis.
- Lipoatrophy, lipodystrophy, and insulin resistance.
- Efficacy and safety of pravastatin in the treatment of patients with type I or type II Diabetes mellitus and hypercholesterolemia.
- Hypertension: the major risk factor in juvenile-onset insulin-dependent Diabetics.
- Pathogenesis of macrovascular disease in the human Diabetic.
- Improvement of lipid status in Diabetic boys: the 1971 and 1979 Joslin Camp lipid levels.
- Insulin resistance and monoclonal gammopathy.
- Muscle capillary basement membrane width and its relationship to Diabetes mellitus in monozygotic twins.
- The effect of strict control with the artificial beta-cell on plasma lipid levels in insulin-dependent Diabetes.
- Morbidity and mortality from Diabetes mellitus: a look at preventable aspects.
- Pre-type 1 (insulin-dependent) Diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity.
- Pre-type I Diabetes. Linear loss of beta cell response to intravenous glucose.
- Differential sensitivity to beta-cell secretagogues in "early," type I Diabetes mellitus.
- Pentamidine and Hypoglycemia.
- Type I Diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction.
- Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I Diabetes mellitus.
- Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
- The role of gastrointestinal and neuronal peptides in the pathophysiology of Diabetes mellitus.
- Capillary basement membrane thickness in monozygotic twins.
- Studies on peripheral Metabolism of glucose and free fatty acids (forearm preparation) in various clinical types of Indian diabetics.
- Rheumatoid disease Without joint involvement.
- Delayed toxic effect of busulfan on the marrow.
- Insulin-dependent Diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure.
- First-degree relatives of patients with type I Diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.
- Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two Type II diabetic parents.
- Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4.
- Height-weight indices and blood lipid levels in normal controls and offspring of conjugal Diabetics.
- Diminished A-cell secretion in the early phase of type I Diabetes mellitus.
- Acquired defect in interleukin-2 production in patients with type I Diabetes mellitus.
- Markedly increased erythrocyte sedimentation rate, hyperfibrinogenemia, and peripheral vascular disease in diabetic patients: association With clinical implications.
- Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I Diabetes mellitus.
- Alpha-fetoprotein associated With islet cell tumors.
- Microalbuminuria: measurements, determinants and accompaniments.
- Coronary artery disease is the major determinant of excess mortality in patients with insulin-dependent Diabetes mellitus and persistent proteinuria.
- Hyperfibrinogenemia. An important risk factor for vascular complications in Diabetes.
- Muscle nitrogen Metabolism in chronic hepatic insufficiency.
- Alanine-induced amino acid interrelationships.
- Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
- Hormone-fuel concentrations in anephric subjects. Effect of hemodialysis (With special reference to amino acids).
- Portacaval diversion for severe hypercholesterolemia. Report of a case With measurements of glucose tolerance, insulin, and glucagon levels.
- The effect of physical training on glucose tolerance and plasma lipids in maturity-onset Diabetes.
- Factors governing insulin and glucagon responses during normal meals.
- Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests.
- Metabolic effects of glucose, mannose, galactose, and fructose in man.
- Transient suppression of growth hormone secretion after chronic ethanol intake.
- Genetic, acquired, and related factors in the etiology of Diabetes mellitus.
- "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas.
- "Somatostatinoma": follow-up studies.
- Monozygotic triplets with discordance for Diabetes mellitus and diabetic microangiopathy.
- Studies on streptozotocin Diabetes.
- A comparison of thyroxine and desicatted thyroid in patients With primary hypothyroidism.
- Management of patients with Diabetes and "abnormal" blood pressure: selection of antihypertensive agents.
Schools
Sawai Man Singh Medical College Rajasthan University
All India Institute Med Scis
Boston Va Hospital
Lemuel Shattuck Hospital
Peter Bent Brigham Hospital
Procedures Preformed
- Continuous Glucose Monitoring
Conditions Treated
- Calcium Metabolism Disorders
- Cushing's Syndrome
- Diabetes Insipidus
- Diabetes Mellitus, Secondary
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Diabetes Recognition Program
Education
-
Brigham and Women's Hospital -
Sawai Man Singh Medical College
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1134298938 | |
| NPPES Provider LastName | GANDA | |
| NPPES Provider FirstName | OM | |
| NPPES Provider ZIPCode | 022155306 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 2181.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134298938 |
| Last Name Of The Provider | GANDA |
| First Name Of The Provider | OM |
| View All |
Similar Doctors
|
|
Dr. Isaac S. Kohane, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Whitney Woodmansee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin E. Kershaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily D. Szmuilowicz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard A. Wolpert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet Lo, MD
This Doctor is OpenDoctor Recommended.
|